| St. Ann Clinic, St. Ann Dental Services, St. Ann Community Outreach Se | |
|
1436 Locust Street Terre Haute IN 47807-1648 | |
| (812) 232-7447 | |
| (812) 232-6962 |
| Full Name | St. Ann Clinic, St. Ann Dental Services, St. Ann Community Outreach Se |
|---|---|
| Speciality | Clinic/Center |
| Location | 1436 Locust Street, Terre Haute, Indiana |
| Authorized Official Name and Position | Peter Cook Ciancone (PRESIDENT OF THE BOARD OF DIRECTORS) |
| Authorized Official Contact | 8122406056 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| St. Ann Clinic, St. Ann Dental Services, St. Ann Community Outreach Se 1436 Locust Street Terre Haute IN 47807-1648 Ph: (812) 232-7447 | St. Ann Clinic, St. Ann Dental Services, St. Ann Community Outreach Se 1436 Locust Street Terre Haute IN 47807-1648 Ph: (812) 232-7447 |
| NPI Number | 1891044681 |
|---|---|
| Provider Enumeration Date | 09/07/2012 |
| Last Update Date | 06/29/2020 |
| Medicare PECOS PAC ID | 4880848530 |
|---|---|
| Medicare Enrollment ID | O20130204000433 |
News Archive
In a statement released yesterday, the International Society for Stem Cell Research called for a moratorium on attempts at clinical application of nuclear genome editing of the human germ line to enable more extensive scientific analysis of the potential risks of genome editing and broader public discussion of the societal and ethical implications.
McCord Research the parent company of Pinnaclife warns consumers that fruit that is protected from infestation or bacteria by an ingredient as common as clove oil could cause an allergic skin reaction.
Illumina, Inc. announced today that District Judge Sue L. Robinson of the U.S. District Court for the District of Delaware granted Illumina's motion for summary judgment of invalidity of U.S. Patent No. 7,593,109, a patent asserted by Helicos BioSciences Corporation in a lawsuit filed against Illumina in October 2010. Judge Robinson ruled that the '109 patent was invalid for inadequate written description.
On June 12th, Loyola University Medical Center hosted four of Southeast Asia's top orthopaedic surgeons. They are Hein Latt Win, MD, of Myanmar, who specializes in hip replacements; Istan Irsan of Indonesia (orthopaedic tumors); Azura Mansor of Malaysia (orthopaedic tumors); and Chia-Liang Ang of Sinapore (orthopaedic tumors and hip and knee replacements).
In a recent medRxiv research paper, the US scientists examined the effects of non-synonymous mutations in the circulating B.1.1.7 strain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on linear antibody epitope signal for viral spike glycoprotein and nucleoprotein – and demonstrated that mutations should not result in immune evasion.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891044681 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | (* (Not Available)) | Primary |
| Provider Name | Mark D Crowley |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1568442481 PECOS PAC ID: 4789657933 Enrollment ID: I20040816001048 |
News Archive
In a statement released yesterday, the International Society for Stem Cell Research called for a moratorium on attempts at clinical application of nuclear genome editing of the human germ line to enable more extensive scientific analysis of the potential risks of genome editing and broader public discussion of the societal and ethical implications.
McCord Research the parent company of Pinnaclife warns consumers that fruit that is protected from infestation or bacteria by an ingredient as common as clove oil could cause an allergic skin reaction.
Illumina, Inc. announced today that District Judge Sue L. Robinson of the U.S. District Court for the District of Delaware granted Illumina's motion for summary judgment of invalidity of U.S. Patent No. 7,593,109, a patent asserted by Helicos BioSciences Corporation in a lawsuit filed against Illumina in October 2010. Judge Robinson ruled that the '109 patent was invalid for inadequate written description.
On June 12th, Loyola University Medical Center hosted four of Southeast Asia's top orthopaedic surgeons. They are Hein Latt Win, MD, of Myanmar, who specializes in hip replacements; Istan Irsan of Indonesia (orthopaedic tumors); Azura Mansor of Malaysia (orthopaedic tumors); and Chia-Liang Ang of Sinapore (orthopaedic tumors and hip and knee replacements).
In a recent medRxiv research paper, the US scientists examined the effects of non-synonymous mutations in the circulating B.1.1.7 strain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on linear antibody epitope signal for viral spike glycoprotein and nucleoprotein – and demonstrated that mutations should not result in immune evasion.
› Verified 5 days ago
| Provider Name | Cristina L Werremeyer |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1376577866 PECOS PAC ID: 1254360134 Enrollment ID: I20050810001260 |
News Archive
In a statement released yesterday, the International Society for Stem Cell Research called for a moratorium on attempts at clinical application of nuclear genome editing of the human germ line to enable more extensive scientific analysis of the potential risks of genome editing and broader public discussion of the societal and ethical implications.
McCord Research the parent company of Pinnaclife warns consumers that fruit that is protected from infestation or bacteria by an ingredient as common as clove oil could cause an allergic skin reaction.
Illumina, Inc. announced today that District Judge Sue L. Robinson of the U.S. District Court for the District of Delaware granted Illumina's motion for summary judgment of invalidity of U.S. Patent No. 7,593,109, a patent asserted by Helicos BioSciences Corporation in a lawsuit filed against Illumina in October 2010. Judge Robinson ruled that the '109 patent was invalid for inadequate written description.
On June 12th, Loyola University Medical Center hosted four of Southeast Asia's top orthopaedic surgeons. They are Hein Latt Win, MD, of Myanmar, who specializes in hip replacements; Istan Irsan of Indonesia (orthopaedic tumors); Azura Mansor of Malaysia (orthopaedic tumors); and Chia-Liang Ang of Sinapore (orthopaedic tumors and hip and knee replacements).
In a recent medRxiv research paper, the US scientists examined the effects of non-synonymous mutations in the circulating B.1.1.7 strain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on linear antibody epitope signal for viral spike glycoprotein and nucleoprotein – and demonstrated that mutations should not result in immune evasion.
› Verified 5 days ago
| Provider Name | Jessy G Woods |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1427275353 PECOS PAC ID: 6608977327 Enrollment ID: I20070725000472 |
News Archive
In a statement released yesterday, the International Society for Stem Cell Research called for a moratorium on attempts at clinical application of nuclear genome editing of the human germ line to enable more extensive scientific analysis of the potential risks of genome editing and broader public discussion of the societal and ethical implications.
McCord Research the parent company of Pinnaclife warns consumers that fruit that is protected from infestation or bacteria by an ingredient as common as clove oil could cause an allergic skin reaction.
Illumina, Inc. announced today that District Judge Sue L. Robinson of the U.S. District Court for the District of Delaware granted Illumina's motion for summary judgment of invalidity of U.S. Patent No. 7,593,109, a patent asserted by Helicos BioSciences Corporation in a lawsuit filed against Illumina in October 2010. Judge Robinson ruled that the '109 patent was invalid for inadequate written description.
On June 12th, Loyola University Medical Center hosted four of Southeast Asia's top orthopaedic surgeons. They are Hein Latt Win, MD, of Myanmar, who specializes in hip replacements; Istan Irsan of Indonesia (orthopaedic tumors); Azura Mansor of Malaysia (orthopaedic tumors); and Chia-Liang Ang of Sinapore (orthopaedic tumors and hip and knee replacements).
In a recent medRxiv research paper, the US scientists examined the effects of non-synonymous mutations in the circulating B.1.1.7 strain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on linear antibody epitope signal for viral spike glycoprotein and nucleoprotein – and demonstrated that mutations should not result in immune evasion.
› Verified 5 days ago
| Provider Name | Brooke A Kempf |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1316257645 PECOS PAC ID: 1759570468 Enrollment ID: I20110112000158 |
News Archive
In a statement released yesterday, the International Society for Stem Cell Research called for a moratorium on attempts at clinical application of nuclear genome editing of the human germ line to enable more extensive scientific analysis of the potential risks of genome editing and broader public discussion of the societal and ethical implications.
McCord Research the parent company of Pinnaclife warns consumers that fruit that is protected from infestation or bacteria by an ingredient as common as clove oil could cause an allergic skin reaction.
Illumina, Inc. announced today that District Judge Sue L. Robinson of the U.S. District Court for the District of Delaware granted Illumina's motion for summary judgment of invalidity of U.S. Patent No. 7,593,109, a patent asserted by Helicos BioSciences Corporation in a lawsuit filed against Illumina in October 2010. Judge Robinson ruled that the '109 patent was invalid for inadequate written description.
On June 12th, Loyola University Medical Center hosted four of Southeast Asia's top orthopaedic surgeons. They are Hein Latt Win, MD, of Myanmar, who specializes in hip replacements; Istan Irsan of Indonesia (orthopaedic tumors); Azura Mansor of Malaysia (orthopaedic tumors); and Chia-Liang Ang of Sinapore (orthopaedic tumors and hip and knee replacements).
In a recent medRxiv research paper, the US scientists examined the effects of non-synonymous mutations in the circulating B.1.1.7 strain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on linear antibody epitope signal for viral spike glycoprotein and nucleoprotein – and demonstrated that mutations should not result in immune evasion.
› Verified 5 days ago
| Provider Name | Melinda S Hendrix |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1114391281 PECOS PAC ID: 9830489228 Enrollment ID: I20160525002893 |
News Archive
In a statement released yesterday, the International Society for Stem Cell Research called for a moratorium on attempts at clinical application of nuclear genome editing of the human germ line to enable more extensive scientific analysis of the potential risks of genome editing and broader public discussion of the societal and ethical implications.
McCord Research the parent company of Pinnaclife warns consumers that fruit that is protected from infestation or bacteria by an ingredient as common as clove oil could cause an allergic skin reaction.
Illumina, Inc. announced today that District Judge Sue L. Robinson of the U.S. District Court for the District of Delaware granted Illumina's motion for summary judgment of invalidity of U.S. Patent No. 7,593,109, a patent asserted by Helicos BioSciences Corporation in a lawsuit filed against Illumina in October 2010. Judge Robinson ruled that the '109 patent was invalid for inadequate written description.
On June 12th, Loyola University Medical Center hosted four of Southeast Asia's top orthopaedic surgeons. They are Hein Latt Win, MD, of Myanmar, who specializes in hip replacements; Istan Irsan of Indonesia (orthopaedic tumors); Azura Mansor of Malaysia (orthopaedic tumors); and Chia-Liang Ang of Sinapore (orthopaedic tumors and hip and knee replacements).
In a recent medRxiv research paper, the US scientists examined the effects of non-synonymous mutations in the circulating B.1.1.7 strain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on linear antibody epitope signal for viral spike glycoprotein and nucleoprotein – and demonstrated that mutations should not result in immune evasion.
› Verified 5 days ago
| Provider Name | Kimberly Beth Smith |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1629118195 PECOS PAC ID: 8325096217 Enrollment ID: I20171226001198 |
News Archive
In a statement released yesterday, the International Society for Stem Cell Research called for a moratorium on attempts at clinical application of nuclear genome editing of the human germ line to enable more extensive scientific analysis of the potential risks of genome editing and broader public discussion of the societal and ethical implications.
McCord Research the parent company of Pinnaclife warns consumers that fruit that is protected from infestation or bacteria by an ingredient as common as clove oil could cause an allergic skin reaction.
Illumina, Inc. announced today that District Judge Sue L. Robinson of the U.S. District Court for the District of Delaware granted Illumina's motion for summary judgment of invalidity of U.S. Patent No. 7,593,109, a patent asserted by Helicos BioSciences Corporation in a lawsuit filed against Illumina in October 2010. Judge Robinson ruled that the '109 patent was invalid for inadequate written description.
On June 12th, Loyola University Medical Center hosted four of Southeast Asia's top orthopaedic surgeons. They are Hein Latt Win, MD, of Myanmar, who specializes in hip replacements; Istan Irsan of Indonesia (orthopaedic tumors); Azura Mansor of Malaysia (orthopaedic tumors); and Chia-Liang Ang of Sinapore (orthopaedic tumors and hip and knee replacements).
In a recent medRxiv research paper, the US scientists examined the effects of non-synonymous mutations in the circulating B.1.1.7 strain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on linear antibody epitope signal for viral spike glycoprotein and nucleoprotein – and demonstrated that mutations should not result in immune evasion.
› Verified 5 days ago
| Provider Name | Emily S Owens |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1174038889 PECOS PAC ID: 3274894688 Enrollment ID: I20180228000262 |
News Archive
In a statement released yesterday, the International Society for Stem Cell Research called for a moratorium on attempts at clinical application of nuclear genome editing of the human germ line to enable more extensive scientific analysis of the potential risks of genome editing and broader public discussion of the societal and ethical implications.
McCord Research the parent company of Pinnaclife warns consumers that fruit that is protected from infestation or bacteria by an ingredient as common as clove oil could cause an allergic skin reaction.
Illumina, Inc. announced today that District Judge Sue L. Robinson of the U.S. District Court for the District of Delaware granted Illumina's motion for summary judgment of invalidity of U.S. Patent No. 7,593,109, a patent asserted by Helicos BioSciences Corporation in a lawsuit filed against Illumina in October 2010. Judge Robinson ruled that the '109 patent was invalid for inadequate written description.
On June 12th, Loyola University Medical Center hosted four of Southeast Asia's top orthopaedic surgeons. They are Hein Latt Win, MD, of Myanmar, who specializes in hip replacements; Istan Irsan of Indonesia (orthopaedic tumors); Azura Mansor of Malaysia (orthopaedic tumors); and Chia-Liang Ang of Sinapore (orthopaedic tumors and hip and knee replacements).
In a recent medRxiv research paper, the US scientists examined the effects of non-synonymous mutations in the circulating B.1.1.7 strain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on linear antibody epitope signal for viral spike glycoprotein and nucleoprotein – and demonstrated that mutations should not result in immune evasion.
› Verified 5 days ago
| Provider Name | Melissa Burns |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1285190041 PECOS PAC ID: 9537409115 Enrollment ID: I20190318001728 |
News Archive
In a statement released yesterday, the International Society for Stem Cell Research called for a moratorium on attempts at clinical application of nuclear genome editing of the human germ line to enable more extensive scientific analysis of the potential risks of genome editing and broader public discussion of the societal and ethical implications.
McCord Research the parent company of Pinnaclife warns consumers that fruit that is protected from infestation or bacteria by an ingredient as common as clove oil could cause an allergic skin reaction.
Illumina, Inc. announced today that District Judge Sue L. Robinson of the U.S. District Court for the District of Delaware granted Illumina's motion for summary judgment of invalidity of U.S. Patent No. 7,593,109, a patent asserted by Helicos BioSciences Corporation in a lawsuit filed against Illumina in October 2010. Judge Robinson ruled that the '109 patent was invalid for inadequate written description.
On June 12th, Loyola University Medical Center hosted four of Southeast Asia's top orthopaedic surgeons. They are Hein Latt Win, MD, of Myanmar, who specializes in hip replacements; Istan Irsan of Indonesia (orthopaedic tumors); Azura Mansor of Malaysia (orthopaedic tumors); and Chia-Liang Ang of Sinapore (orthopaedic tumors and hip and knee replacements).
In a recent medRxiv research paper, the US scientists examined the effects of non-synonymous mutations in the circulating B.1.1.7 strain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on linear antibody epitope signal for viral spike glycoprotein and nucleoprotein – and demonstrated that mutations should not result in immune evasion.
› Verified 5 days ago
| Provider Name | Katie Sanders |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1710522008 PECOS PAC ID: 1658700737 Enrollment ID: I20200413000681 |
News Archive
In a statement released yesterday, the International Society for Stem Cell Research called for a moratorium on attempts at clinical application of nuclear genome editing of the human germ line to enable more extensive scientific analysis of the potential risks of genome editing and broader public discussion of the societal and ethical implications.
McCord Research the parent company of Pinnaclife warns consumers that fruit that is protected from infestation or bacteria by an ingredient as common as clove oil could cause an allergic skin reaction.
Illumina, Inc. announced today that District Judge Sue L. Robinson of the U.S. District Court for the District of Delaware granted Illumina's motion for summary judgment of invalidity of U.S. Patent No. 7,593,109, a patent asserted by Helicos BioSciences Corporation in a lawsuit filed against Illumina in October 2010. Judge Robinson ruled that the '109 patent was invalid for inadequate written description.
On June 12th, Loyola University Medical Center hosted four of Southeast Asia's top orthopaedic surgeons. They are Hein Latt Win, MD, of Myanmar, who specializes in hip replacements; Istan Irsan of Indonesia (orthopaedic tumors); Azura Mansor of Malaysia (orthopaedic tumors); and Chia-Liang Ang of Sinapore (orthopaedic tumors and hip and knee replacements).
In a recent medRxiv research paper, the US scientists examined the effects of non-synonymous mutations in the circulating B.1.1.7 strain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on linear antibody epitope signal for viral spike glycoprotein and nucleoprotein – and demonstrated that mutations should not result in immune evasion.
› Verified 5 days ago
| Provider Name | Lesli Bose |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1376165258 PECOS PAC ID: 7517388705 Enrollment ID: I20200526000558 |
News Archive
In a statement released yesterday, the International Society for Stem Cell Research called for a moratorium on attempts at clinical application of nuclear genome editing of the human germ line to enable more extensive scientific analysis of the potential risks of genome editing and broader public discussion of the societal and ethical implications.
McCord Research the parent company of Pinnaclife warns consumers that fruit that is protected from infestation or bacteria by an ingredient as common as clove oil could cause an allergic skin reaction.
Illumina, Inc. announced today that District Judge Sue L. Robinson of the U.S. District Court for the District of Delaware granted Illumina's motion for summary judgment of invalidity of U.S. Patent No. 7,593,109, a patent asserted by Helicos BioSciences Corporation in a lawsuit filed against Illumina in October 2010. Judge Robinson ruled that the '109 patent was invalid for inadequate written description.
On June 12th, Loyola University Medical Center hosted four of Southeast Asia's top orthopaedic surgeons. They are Hein Latt Win, MD, of Myanmar, who specializes in hip replacements; Istan Irsan of Indonesia (orthopaedic tumors); Azura Mansor of Malaysia (orthopaedic tumors); and Chia-Liang Ang of Sinapore (orthopaedic tumors and hip and knee replacements).
In a recent medRxiv research paper, the US scientists examined the effects of non-synonymous mutations in the circulating B.1.1.7 strain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on linear antibody epitope signal for viral spike glycoprotein and nucleoprotein – and demonstrated that mutations should not result in immune evasion.
› Verified 5 days ago
| Provider Name | Beth Frederick |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1699371500 PECOS PAC ID: 8426463043 Enrollment ID: I20210212000595 |
News Archive
In a statement released yesterday, the International Society for Stem Cell Research called for a moratorium on attempts at clinical application of nuclear genome editing of the human germ line to enable more extensive scientific analysis of the potential risks of genome editing and broader public discussion of the societal and ethical implications.
McCord Research the parent company of Pinnaclife warns consumers that fruit that is protected from infestation or bacteria by an ingredient as common as clove oil could cause an allergic skin reaction.
Illumina, Inc. announced today that District Judge Sue L. Robinson of the U.S. District Court for the District of Delaware granted Illumina's motion for summary judgment of invalidity of U.S. Patent No. 7,593,109, a patent asserted by Helicos BioSciences Corporation in a lawsuit filed against Illumina in October 2010. Judge Robinson ruled that the '109 patent was invalid for inadequate written description.
On June 12th, Loyola University Medical Center hosted four of Southeast Asia's top orthopaedic surgeons. They are Hein Latt Win, MD, of Myanmar, who specializes in hip replacements; Istan Irsan of Indonesia (orthopaedic tumors); Azura Mansor of Malaysia (orthopaedic tumors); and Chia-Liang Ang of Sinapore (orthopaedic tumors and hip and knee replacements).
In a recent medRxiv research paper, the US scientists examined the effects of non-synonymous mutations in the circulating B.1.1.7 strain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on linear antibody epitope signal for viral spike glycoprotein and nucleoprotein – and demonstrated that mutations should not result in immune evasion.
› Verified 5 days ago
| Provider Name | Miranda Collins |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1215647375 PECOS PAC ID: 6901260710 Enrollment ID: I20230913000281 |
News Archive
In a statement released yesterday, the International Society for Stem Cell Research called for a moratorium on attempts at clinical application of nuclear genome editing of the human germ line to enable more extensive scientific analysis of the potential risks of genome editing and broader public discussion of the societal and ethical implications.
McCord Research the parent company of Pinnaclife warns consumers that fruit that is protected from infestation or bacteria by an ingredient as common as clove oil could cause an allergic skin reaction.
Illumina, Inc. announced today that District Judge Sue L. Robinson of the U.S. District Court for the District of Delaware granted Illumina's motion for summary judgment of invalidity of U.S. Patent No. 7,593,109, a patent asserted by Helicos BioSciences Corporation in a lawsuit filed against Illumina in October 2010. Judge Robinson ruled that the '109 patent was invalid for inadequate written description.
On June 12th, Loyola University Medical Center hosted four of Southeast Asia's top orthopaedic surgeons. They are Hein Latt Win, MD, of Myanmar, who specializes in hip replacements; Istan Irsan of Indonesia (orthopaedic tumors); Azura Mansor of Malaysia (orthopaedic tumors); and Chia-Liang Ang of Sinapore (orthopaedic tumors and hip and knee replacements).
In a recent medRxiv research paper, the US scientists examined the effects of non-synonymous mutations in the circulating B.1.1.7 strain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on linear antibody epitope signal for viral spike glycoprotein and nucleoprotein – and demonstrated that mutations should not result in immune evasion.
› Verified 5 days ago
News Archive
In a statement released yesterday, the International Society for Stem Cell Research called for a moratorium on attempts at clinical application of nuclear genome editing of the human germ line to enable more extensive scientific analysis of the potential risks of genome editing and broader public discussion of the societal and ethical implications.
McCord Research the parent company of Pinnaclife warns consumers that fruit that is protected from infestation or bacteria by an ingredient as common as clove oil could cause an allergic skin reaction.
Illumina, Inc. announced today that District Judge Sue L. Robinson of the U.S. District Court for the District of Delaware granted Illumina's motion for summary judgment of invalidity of U.S. Patent No. 7,593,109, a patent asserted by Helicos BioSciences Corporation in a lawsuit filed against Illumina in October 2010. Judge Robinson ruled that the '109 patent was invalid for inadequate written description.
On June 12th, Loyola University Medical Center hosted four of Southeast Asia's top orthopaedic surgeons. They are Hein Latt Win, MD, of Myanmar, who specializes in hip replacements; Istan Irsan of Indonesia (orthopaedic tumors); Azura Mansor of Malaysia (orthopaedic tumors); and Chia-Liang Ang of Sinapore (orthopaedic tumors and hip and knee replacements).
In a recent medRxiv research paper, the US scientists examined the effects of non-synonymous mutations in the circulating B.1.1.7 strain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on linear antibody epitope signal for viral spike glycoprotein and nucleoprotein – and demonstrated that mutations should not result in immune evasion.
› Verified 5 days ago
Illiana Internal Medicine, L.l.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1332 N 7th St, Terre Haute, IN 47807 Phone: 812-478-8888 Fax: 812-478-1114 | |
Ambucare Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3387 S Us Highway 41, Terre Haute, IN 47802 Phone: 812-232-5532 Fax: 812-232-2574 | |
Union Hospital Family Medicine East Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4001 Wabash Ave, Terre Haute, IN 47803 Phone: 812-238-7711 Fax: 812-238-7700 | |
Associated Physicians & Surgeons Clinic, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4601 S 7th St, Terre Haute, IN 47802 Phone: 812-232-0564 Fax: 812-242-3848 | |
Hpw Center For Diabetes, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3560 S 4th St, Terre Haute, IN 47802 Phone: 812-235-8496 Fax: 812-478-1540 | |
No Dba Wabash Valley Hospitalists Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3901 S 7th St, Room 452, Terre Haute, IN 47802 Phone: 812-237-9217 Fax: 812-237-1395 | |
Union Associated Physicians Clinic, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1725 N 5th St, Terre Haute, IN 47804 Phone: 812-242-3005 Fax: 812-242-3034 |